References
- Australian Institute of Health and Welfare (AIHW). Alcohol and other drug treatment services in Australia 2004 – 05: report on the national minimum data set. AIHW, Canberra 2006, Drug Treatment Series 5. AIHW cat. no. HSE 43
- Australian Institute of Health and Welfare (AIHW). Alcohol and other drug treatment services in Australia 2001 – 02: report on the national minimum data set. AIHW, Canberra 2003, Drug Treatment Series 2. AIHW cat. no. HSE 28
- Matheson C, Bond C M, Pitcairn J. Community pharmacy services for drug misusers in Scotland: what difference does 5 years make?. Addiction 2002; 97: 1405–1411
- Hurley M. Guide for pharmacists: addiction treatment and maintenance pharmacotherapy (methadone and buprenorphine) programs in South Australia. Parkside: Drug and Alcohol Services Council, Government of South Australia. 2004
- Healthcare Management Advisors. Development, implementation and evaluation of funding model options for the dispensing of pharmacotherapies for opioid dependence in community pharmacy. Pharmacy Guild of Australia. 2003, Unpublished document
- Hotham E, Roche A, Skinner N, Dollman B. The general practitioner pharmacotherapy prescribing workforce: examining sustainability from a systems perspective. Drug Alcohol Rev 2005; 24: 1–8
- Muhleisen P, Lintzeris N, Koutroulis G, et al. Evaluation of methadone dispensing in community pharmacies in Victoria. Aust Pharm 1998; 17(suppl)7–12
- Peterson G M. Drug misuse and harm reduction: pharmacy's magnificent contribution, but at what cost?. J Clin Pharm Ther 1999; 24: 165–169
- Le P P, Hotham E D. Exploring the dissonance between business and public health policy: pharmacy and the provision of opioid pharmacotherapies and clean needles in rural settings. Int J Pharm Pract 2006; 14: 63–70
- Australian Bureau of Statistics (ABS). Australian demographic statistics. ABS cat. no. 3101.0. ABS, Canberra 2004
- Berbatis C G, Sunderland V B. The role of community pharmacy in methadone maintenance treatment: an evaluation through a literature review, prospective, retrospective and other studies conducted in Australia and overseas from 1998 – 2000. Australian Association of Consultant Pharmacy, Barton 2001
- Jesson J, Wilson K, Barton A, Pocock R. Exploring the potential for supervised methadone consumption and shared care contracts with drug misusers. Pharm J 2000; 265: R37, (Pharmacy Practice Research Supplement, Sept. 16)
- SPSS Inc. SPSS release 12.0. SPSS Inc., Chicago, IL 2003
- Sheridan J, Cronin F. Supervised self-administration of methadone at community pharmacies: the introduction of a new service. Pharm J 2002; 268: 471–474
- Muhleisen P, Panjari M, Lee N. Buprenorphine dispensing in a cohort of community pharmacies in Victoria. Aust Pharm 2003; 22: 229–234
- Matheson C, Bond C M, Mollison J. Attitudinal factors associated with community pharmacists' involvement in services for drug misusers. Addiction 1999; 94: 1349–1359